Status: current, Defined. Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4953832015 | Product containing precisely pyrazinamide 150 milligram/1 each tablet for conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4953833013 | Pyrazinamide 150 mg tablet for oral suspension | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pyrazinamide 150 mg tablet for oral suspension | Is a | Pyrazinamide only product in oral dose form | true | Inferred relationship | Some | ||
| Pyrazinamide 150 mg tablet for oral suspension | Has manufactured dose form | Tablet for oral suspension | true | Inferred relationship | Some | ||
| Pyrazinamide 150 mg tablet for oral suspension | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
| Pyrazinamide 150 mg tablet for oral suspension | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Some | ||
| Pyrazinamide 150 mg tablet for oral suspension | Has precise active ingredient | Pyrazinamide | true | Inferred relationship | Some | 1 | |
| Pyrazinamide 150 mg tablet for oral suspension | Has BoSS | Pyrazinamide | true | Inferred relationship | Some | 1 | |
| Pyrazinamide 150 mg tablet for oral suspension | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Pyrazinamide 150 mg tablet for oral suspension | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR